<SEC-DOCUMENT>0001654954-21-009710-index.html : 20210902 <SEC-HEADER>0001654954-21-009710.hdr.sgml : 20210902 <ACCEPTANCE-DATETIME>20210902163114 ACCESSION NUMBER: 0001654954-21-009710 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20210902 DATE AS OF CHANGE: 20210902 EFFECTIVENESS DATE: 20210902 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TENAX THERAPEUTICS, INC. CENTRAL INDEX KEY: 0000034956 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262593535 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-259266 FILM NUMBER: 211233664 BUSINESS ADDRESS: STREET 1: ONE COPLEY PARKWAY STREET 2: SUITE 490 CITY: MORRISVILLE STATE: NC ZIP: 27560 BUSINESS PHONE: 919-806-4414 MAIL ADDRESS: STREET 1: ONE COPLEY PARKWAY STREET 2: SUITE 490 CITY: MORRISVILLE STATE: NC ZIP: 27560 FORMER COMPANY: FORMER CONFORMED NAME: OXYGEN BIOTHERAPEUTICS, INC. DATE OF NAME CHANGE: 20080703 FORMER COMPANY: FORMER CONFORMED NAME: SYNTHETIC BLOOD INTERNATIONAL INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SINEQUANON CORP DATE OF NAME CHANGE: 19901219 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>tenx_s8.htm <DESCRIPTION>PRIMARY DOCUMENT <TEXT> Document 1 - file: tenx_s8.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>tenx_ex51.htm <DESCRIPTION>OPINION ON LEGALITY <TEXT> Document 2 - file: tenx_ex51.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>tenx_ex231.htm <DESCRIPTION>CONSENTS OF EXPERTS AND COUNSEL <TEXT> Document 3 - file: tenx_ex231.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.4 <SEQUENCE>4 <FILENAME>tenx_ex994.htm <DESCRIPTION>PLAN FOR EMPLOYEE INDUCEMENT <TEXT> Document 4 - file: tenx_ex994.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>tenx_ex51000.jpg <DESCRIPTION>IMAGE <TEXT> Document 5 - file: tenx_ex51000.jpg
</DOCUMENT> </SEC-DOCUMENT>